<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="In this paper, we review the literature about the common" exact="treatment" post="of pemphigus with a focus on the lessons from"/>
 <result pre="era. The effect of many of the drugs used for" exact="treatment" post="of Pemphigus vulgaris (PV) on COVID-19 is not clear."/>
 <result pre="combination with immunosuppressive drugs, have been used as the mainstay" exact="treatment" post="in pemphigus vulgaris (7). Although these agents have led"/>
 <result pre="led to substantial improvement in the prognosis of the disease," exact="treatment" post="complications, especially the risk of infections, remain major areas"/>
 <result pre="data have not confirmed the beneficial effect of corticosteroids in" exact="treatment" post="of respiratory infections due to SARS-CoV, or MERS-CoV (12)."/>
 <result pre="(12). The observational studies had reported increased mortality and secondary" exact="infection" post="rates in influenza, impaired clearance of SARS-CoV and MERS-CoV,"/>
 <result pre="Therefore, not only does the role of steroids in the" exact="treatment" post="of acute lung injury in these viral infections remain"/>
 <result pre="injury in these viral infections remain controversial, but also this" exact="treatment" post="may be harmful in patients with 2019-nCoV infection (12,"/>
 <result pre="also this treatment may be harmful in patients with 2019-nCoV" exact="infection" post="(12, 15). Currently, pandemic-related emotional stress, decreasing the dose"/>
 <result pre="immunosuppressive medications for fear of COVID-19 and eventually getting this" exact="infection" post="may be considered as exacerbating factors or triggers for"/>
 <result pre="to health principles and avoiding emotional stress while continuing the" exact="treatment" post="protocol recommended by dermatologists may help prevent exacerbation or"/>
 <result pre="that causes depletion of CD20-expressing B cells (17, 18). Early" exact="treatment" post="with rituximab has resulted in higher remission rates, long"/>
 <result pre="and life-threatening infections, including sepsis, have been reported following RTX" exact="treatment" post="(21). Opportunistic infections such as cytomegalovirus infection and Pneumocystis"/>
 <result pre="reported following RTX treatment (21). Opportunistic infections such as cytomegalovirus" exact="infection" post="and Pneumocystis pneumonia (PCP), although extremely rare and limited"/>
 <result pre="(CNS) requires peripheral CD19-dependent germinal center formation following neurotrophic coronavirus" exact="infection" post="(24) and there are evidence that show SARS-CoV-2 targets"/>
 <result pre="weighed against the prominent and effective role of RTX in" exact="treatment" post="of pemphigus and reducing the number of follow up"/>
 <result pre="(AZA) or mycophenolate mofetil (MMF) as first-line steroid-sparing agents for" exact="treatment" post="of pemphigus rather than other adjuvant immunosuppressants (18). Nevertheless,"/>
 <result pre="safest immunomodulator for long-term use in all age groups (29)," exact="treatment" post="with IVIg has been proposed as a potential option"/>
 <result pre="severely ill patients (30). Recommendations Patients with pemphigus need proper" exact="treatment" post="for their underlying condition; however, during the outbreak of"/>
 <result pre="during the COVID-19 outbreak based on the former consensus on" exact="treatment" post="of pemphigus and the current evidence on COVID-19. The"/>
 <result pre="should be followed at regular intervals with a focus on" exact="screening" post="the patients for symptoms of COVID-19. Healthcare professionals who"/>
 <result pre="month that do not disappear within 1 week without additional" exact="treatment" post="IVIG: intravenous immunoglobulin(18) Conclusion: We are currently in the"/>
 <result pre="care. The effect of many of the drugs used for" exact="treatment" post="of Pemphigus vulgaris (PV) on COVID-19 is not clear."/>
 <result pre="current evidence Int J Antimicrob Agents202010594832201353 7ZhaoCYMurrellDFPemphigus vulgaris: an evidence-based" exact="treatment" post="update Drugs20157532718425655250 8GheisariMFarajiZDadrasMSNasiriSRobatiRMMoravvejHet al.Methylprednisolone pulse therapy plus adjuvant therapy"/>
 <result pre="patients Dermatol Ther2019325e1305731400243 9KunisakiKMJanoffENInfluenza in immunosuppressed populations: a review of" exact="infection" post="frequency, morbidity, mortality, and vaccine responses Lancet Infect Dis20099849350419628174"/>
 <result pre="patients J Dermatolog Treat2018298802529668335 12RussellCDMillarJEBaillieJKClinical evidence does not support corticosteroid" exact="treatment" post="for 2019-nCoV lung injury Lancet202039510223473532043983 13StockmanLJBellamyRGarnerPSARS: systematic review of"/>
 <result pre="treatment for 2019-nCoV lung injury Lancet202039510223473532043983 13StockmanLJBellamyRGarnerPSARS: systematic review of" exact="treatment" post="effects PLoS Med200639e34316968120 14GuoLHanYLiJChenQRenYWuQet al.Long-term outcomes in patients with"/>
 <result pre="Critical Care20192319930917856 16SinhaPChatterjeeMVasudevanBPemphigus vulgaris: A dermatological sequel of severe H1N1" exact="infection" post="Indian Dermatol Online J201452216724860767 17DidonaDMaglieREmingRHertlMPemphigus: Current and Future Therapeutic"/>
 <result pre="rituximab combined with short-term prednisone versus prednisone alone for the" exact="treatment" post="of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label"/>
 <result pre="J Dtsch Dermatol Ges201210107273322577946 22ChiuH-YChangC-YHsiaoC-HWangL-FConcurrent cytomegalovirus and herpes simplex virus" exact="infection" post="in pemphigus vulgaris treated with rituximab and prednisolone Acta"/>
 <result pre="vulgaris treated with rituximab and prednisolone Acta Derm Venereol2013932200122948546 23WeiKWangYWangWChenWFatal" exact="infection" post="of Pneumocystis jiroveci pneumonia in a pemphigus patient treated"/>
 <result pre="meta-analysis J Am Acad Dermatol20157322647126088689 27KimS-HKoJ-HParkGEChoSYHaYEKangJ-Met al.Atypical presentations of MERS-CoV" exact="infection" post="in immunocompromised hosts J Infect Chem2017231176973 28BrownAEMotaparthiKHsuSRituximab and intravenous"/>
 <result pre="intravenous immunoglobulin as alternatives to long-term systemic corticosteroids in the" exact="treatment" post="of pemphigus: a single center case series of 63"/>
</results>
